This webinar presented evidence that many countries include equity alongside cost-effectiveness in health technology assessment decisions. Drawing on 19 years of Australian data, the study found that interventions for children were more likely to receive positive funding recommendations, even after accounting for clinical, economic, and equity factors—highlighting a clear ‘childhood effect’ in decision-making.
Latest Resource
-
ACTA Webinar – Conducting economic evaluation alongside paediatric clinical trials: special considerations and examples
-
Treatment switching in oncology trials and integration into economic modelling practices
-
Distributional cost-effectiveness analysis (DCEA) methods
-
HEAT SIG webinar Economic evaluation alongside clinical trials in the anthropocene
-
ACTA webinar – Estimating inequalities in health using quality-adjusted life expectancy: equity implications for health technology assessment and clinical trials
-
Developing ModRUM: a standardised, generic, modular resource-use measure
-
ACTA Webinar – Discrete choice experiment checklist
-
Development of the Cost-IS (costing implementation strategies) instrument
-
Webinar recording: The economics of trials – reducing waste in research
-
Webinar recording: Identifying and addressing trial design issues early
-
ACTA Webinar: Pre-trial VOI analyses to guide trial prioritisation and data collection
-
Webinar recording: Patient reported outcome endpoints: Optimal development, collection, analysis planning & reporting:
-
Webinar recording: Quantifying Equity Impacts
-
HEAT webinar recording: Design of economic evaluations along the development process
-
HEAT Webinar Recording-Flexible survival models and why we (might) need them
-
HEAT Webinar Recording- Use of Administrative Data for Measuring Events and Healthcare Use
-
HEAT Webinar Recording- Economic Evaluation Alongside Adaptive Trials
-
A pilot study to prospectively estimate the health and economic return on research investment